Review article: The medical management of Crohn's disease
- 1 February 1996
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 10 (1) , 1-22
- https://doi.org/10.1111/j.1365-2036.1996.tb00173.x
Abstract
SUMMARY: The choice of medical therapies for Crohn's disease continues to grow. Although our understanding of the mechanisms of the disease is incomplete, increasing knowledge of the pathogenesis of inflammation in general and Crohn's disease in particular allows targeting of therapies at various points in the immunoinflammatory cascade. In addition, the division of Crohn's disease into subtypes by location, aggressiveness, and the presence or absence of perianal and fistulizing disease allows the tailoring of medical therapy to the individual patient. For those patients with moderate to severe symptoms or frequent flares of disease activity, and those who have required surgical resection, maintenance therapy can substantially reduce the rate of recurrence. Despite these advances, available medical therapies for Crohn's disease remain imperfect, as evidenced by their sometimes substantial toxicities and the continued frequent need for surgery.Keywords
This publication has 212 references indexed in Scilit:
- Effect of oral cyclosporin on renal function in Crohn's diseaseDigestive Diseases and Sciences, 1993
- SulfasalazineDigestive Diseases and Sciences, 1992
- Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's diseaseDigestive Diseases and Sciences, 1992
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Nachweis von Cyclosporin A in der MuttermilchGeburtshilfe und Frauenheilkunde, 1989
- Efficacy of Low-Dose Methotrexate in Rheumatoid ArthritisNew England Journal of Medicine, 1985
- Sulfasalazine-Induced Exacerbation of Ulcerative ColitisNew England Journal of Medicine, 1982
- Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's DiseaseNew England Journal of Medicine, 1980
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980
- Bloody diarrhea—a new complication of sulfasalazineThe Journal of Pediatrics, 1978